相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intravenous Immunoglobulin for the Treatment of Clostridium difficile Infection: A Review
Marwan S. Abougergi et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Therapeutic transplantation of the distal gut microbiota
A. Khoruts et al.
MUCOSAL IMMUNOLOGY (2011)
Glucocorticoids Are Associated With Increased Risk of Short-Term Mortality in Hospitalized Patients With Clostridium difficile-Associated Disease
Rohit Das et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Surgical aspects of fulminant Clostridium difficile Colitis
Parag Butala et al.
AMERICAN JOURNAL OF SURGERY (2010)
Clinical Predictors and Risk Factors for Relapsing Clostridium difficile Infection
Jose Cadena et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2010)
Fidaxomicin: A Macrocyclic Antibiotic for the Management of Clostridium difficile Infection
Karyn M. Sullivan et al.
ANNALS OF PHARMACOTHERAPY (2010)
Success of Self-Administered Home Fecal Transplantation for Chronic Clostridium difficile Infection
Michael S. Silverman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Management of Clostridium difficile Infection: Thinking Inside and Outside the Box
Dale N. Gerding et al.
CLINICAL INFECTIOUS DISEASES (2010)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Clostridium Difficile and Inflammatory Bowel Disease: More Questions than Answers? COMMENT
Ashwin N. Ananthakrishnan et al.
INFLAMMATORY BOWEL DISEASES (2010)
Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole
Ching-Lan Lu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Treatment of Refractory/Recurrent C-difficile-associated Disease by Donated Stool Transplanted Via Colonoscopy A Case Series of 12 Patients
Sonia S. Yoon et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
Fecal Flora Reconstitution for Recurrent Clostridium difficile Infection: Results and Methodology
Faith Rohlke et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
Evaluation of tcdB Real-Time PCR in a Three-Step Diagnostic Algorithm for Detection of Toxigenic Clostridium difficile
Ann M. Larson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
C. difficile Colitis-Predictors of Fatal Outcome
Haig Dudukgian et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2010)
Intravenous immunoglobulin for the treatment of severeClostridium difficilecolitis: An observational study and review of the literature
Marwan S. Abougergi et al.
Journal of Hospital Medicine (2010)
Rifaximin for the Treatment of Recurrent Clostridium difficile Infection After Liver Transplantation: A Case Series
Guy Neff et al.
LIVER TRANSPLANTATION (2010)
A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin
Gerald W. Tannock et al.
MICROBIOLOGY-SGM (2010)
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins
Israel Lowy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Outcomes of emergency colectomy for fulminant Clostridium difficile colitis
Yahya A. Al-Abed et al.
SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND (2010)
Impact of Clostridium difficile on inflammatory bowel disease
Ashwin N. Ananthakrishnan et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial
P. Patrick Basu et al.
Therapeutic Advances in Gastroenterology (2010)
Early colectomy may be associated with improved survival in fulminant Clostridium difficile colitis: an 8-year experience
Christopher W. Seder et al.
AMERICAN JOURNAL OF SURGERY (2009)
Fecal bacteriotherapy for recurrent Clostridium difficile infection
Johan S. Bakken
ANAEROBE (2009)
Rifaximin Redux: Treatment of recurrent Clostridium difficile infections with Rifaximin immediately post-vancomycin treatment
Stuart Johnson et al.
ANAEROBE (2009)
OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C-difficile Infection
Thomas J. Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Intravenous Tigecycline as Adjunctive or Alternative Therapy for Severe Refractory Clostridium difficile Infection
Bjorn L. Herpers et al.
CLINICAL INFECTIOUS DISEASES (2009)
Nitazoxanide versus Vancomycin in Clostridium difficile Infection: A Randomized, Double-Blind Study
Daniel M. Musher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Antimotility Agents for the Treatment of Clostridium difficile Diarrhea and Colitis
Hoonmo L. Koo et al.
CLINICAL INFECTIOUS DISEASES (2009)
Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile Infection
Mary Y. Hu et al.
GASTROENTEROLOGY (2009)
The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review
John O'Horo et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2009)
Rifaximin in Treatment of Recurrent Clostridium difficile-associated Diarrhea: An Uncontrolled Pilot Study
Kevin W. Garey et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes
Stuart Johnson
JOURNAL OF INFECTION (2009)
Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series
A. A. Macconnachie et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2009)
Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy
David M. You et al.
ANNALS OF INTERNAL MEDICINE (2008)
Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea
Kevin W. Garey et al.
ANNALS OF PHARMACOTHERAPY (2008)
Vancomycin for the treatment of Clostridium difficile infection:: For whom is this expensive bullet really magic?
Jacques Pepin
CLINICAL INFECTIOUS DISEASES (2008)
Comparison of clinical and microbiological response to treatment of Clostridium difficile associated disease with metronidazole and vancomycin
Wafa N. Al-Nassir et al.
CLINICAL INFECTIOUS DISEASES (2008)
Emergence of reduced susceptibility to metronidazole in Clostridium difficile
Simon D. Baines et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Metronidazole resistance in Clostridium difficile is heterogeneous
T. Pelaez et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Safety of probiotics: translocation and infection
Min-Tze Liong
NUTRITION REVIEWS (2008)
A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: Efficacy and safety data of a prematurely interrupted trial
Eero Mattila et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2008)
Update on the changing epidemiology of Clostridium difficile-associated disease
Lynne V. McFarland
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2008)
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
Fred A. Zar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Clostridium difficile colitis that fails conventional metronidazole therapy:: response to nitazoxanide
Daniel M. Musher et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Impact of Clostridium difficile on inflammatory bowel disease
Mazen Issa et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Clinical outcomes of intravenous immune globulin in severe Clostridium difficile-associated diarrhea
Paul Juang et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2007)
Incidence of Clostridium difficile infection in inflammatory bowel disease
Joseph F. Rodemann et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain
Francois Lamontagne et al.
ANNALS OF SURGERY (2007)
Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile -: Associated diarrhea
Thomas J. Louie et al.
CLINICAL INFECTIOUS DISEASES (2006)
Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea
Stuart McPherson et al.
DISEASES OF THE COLON & RECTUM (2006)
Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin
JR Ticehurst et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
The outcome of surgery in fulminant Clostridium difficile colitis
K Koss et al.
COLORECTAL DISEASE (2006)
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2005)
Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole
DM Musher et al.
CLINICAL INFECTIOUS DISEASES (2005)
Clostridium difficile toxoid vaccine in recurrent C-difficile-associated diarrhea
S Sougioultzis et al.
GASTROENTEROLOGY (2005)
Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile associated diarrhoea:: preclinical and preliminary clinical data
JT van Dissel et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2005)
Probiotics for recurrent Clostridium difficile disease
SJ Lawrence et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2005)
Treatment of Clostridium difficile-associated disease: old therapies and new strategies
S Aslam et al.
LANCET INFECTIOUS DISEASES (2005)
Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001
LK Archibald et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003:: a changing pattern of disease severity
J Pépin et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea
M Wullt et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Treatment of recurrent Clostridium difficile-associated disease
Christina M. Surawicz
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2004)
Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea
MH Wilcox
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Lactobacillus plantarum 299v for the treatment of recurrent clostridium difficile-associated diarrhoea:: A double-blind, placebo-controlled trial
M Wullt et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2003)
Recurrent Clostridium difficile colitis:: Case series involving 18 patients treated with donor stool administered via a nasogastric tube
J Aas et al.
CLINICAL INFECTIOUS DISEASES (2003)
In vitro activity of 15 antimicrobial agents against clinical isolates of Clostridium difficile in Kuwait
WY Jamal et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis:: Case series and review of the literature
A Apisarnthanarak et al.
CLINICAL INFECTIOUS DISEASES (2002)
Intravenous immunoglobulin for recurrent Clostridium difficile diarrhoea
ILP Beales
GUT (2002)
Breaking the cycle:: Treatment strategies for 163 cases of recurrent Clostridium difficile disease
LV McFarland et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)
Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin
T Peláez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Fulminant Clostridium difficile: An underappreciated and increasing cause of death and complications
RM Dallal et al.
ANNALS OF SURGERY (2002)
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea
L Kyne et al.
LANCET (2001)
The search for a better treatment for recurrent Clostridium difficile disease:: Use of high-dose vancomycin combined with Saccharomyces boulardii
CM Surawicz et al.
CLINICAL INFECTIOUS DISEASES (2000)
In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species
A Marchese et al.
CHEMOTHERAPY (2000)
The effect of probiotics on Clostridium difficile diarrhea
M Pochapin
AMERICAN JOURNAL OF GASTROENTEROLOGY (2000)
分享论文
